FDA OKs Marketing of New Device to Reduce Snoring, Mild OSA
MONDAY, Feb. 8, 2021 -- A new device to reduce snoring and mild obstructive sleep apnea has received marketing authorization by the U.S. Food and Drug Administration, the agency announced Friday.
The eXciteOSA device, available only by prescription...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Food and Drug Administration (FDA) | Marketing | Obstructive Sleep Apnea | Pharmaceuticals | Sleep Apnea | Sleep Disorders | Sleep Medicine | Snoring